ROCKWELL MEDICAL INC (RMTI) Fundamental Analysis & Valuation

NASDAQ:RMTI • US7743743004

Current stock price

0.8882 USD
+0.01 (+1.29%)
At close:
0.9 USD
+0.01 (+1.33%)
After Hours:

This RMTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. RMTI Profitability Analysis

1.1 Basic Checks

  • RMTI had negative earnings in the past year.
  • RMTI had a negative operating cash flow in the past year.
  • In the past 5 years RMTI always reported negative net income.
  • In the past 5 years RMTI reported 4 times negative operating cash flow.
RMTI Yearly Net Income VS EBIT VS OCF VS FCFRMTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10M -20M -30M

1.2 Ratios

  • RMTI's Return On Assets of -9.57% is fine compared to the rest of the industry. RMTI outperforms 60.96% of its industry peers.
  • Looking at the Return On Equity, with a value of -14.78%, RMTI is in the better half of the industry, outperforming 64.17% of the companies in the same industry.
Industry RankSector Rank
ROA -9.57%
ROE -14.78%
ROIC N/A
ROA(3y)-9.02%
ROA(5y)-26.88%
ROE(3y)-18.94%
ROE(5y)-295.09%
ROIC(3y)N/A
ROIC(5y)N/A
RMTI Yearly ROA, ROE, ROICRMTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 18.19%, RMTI is doing worse than 79.68% of the companies in the same industry.
  • RMTI's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for RMTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.22%
GM growth 5Y33.51%
RMTI Yearly Profit, Operating, Gross MarginsRMTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. RMTI Health Analysis

2.1 Basic Checks

  • RMTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • RMTI has more shares outstanding than it did 1 year ago.
  • RMTI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, RMTI has an improved debt to assets ratio.
RMTI Yearly Shares OutstandingRMTI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
RMTI Yearly Total Debt VS Total AssetsRMTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • RMTI has an Altman-Z score of -7.25. This is a bad value and indicates that RMTI is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of RMTI (-7.25) is worse than 76.47% of its industry peers.
  • RMTI has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
  • RMTI has a Debt to Equity ratio of 0.25. This is comparable to the rest of the industry: RMTI outperforms 54.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -7.25
ROIC/WACCN/A
WACC8.37%
RMTI Yearly LT Debt VS Equity VS FCFRMTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M

2.3 Liquidity

  • A Current Ratio of 3.98 indicates that RMTI has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 3.98, RMTI is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • RMTI has a Quick Ratio of 3.63. This indicates that RMTI is financially healthy and has no problem in meeting its short term obligations.
  • RMTI has a better Quick ratio (3.63) than 68.98% of its industry peers.
Industry RankSector Rank
Current Ratio 3.98
Quick Ratio 3.63
RMTI Yearly Current Assets VS Current LiabilitesRMTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. RMTI Growth Analysis

3.1 Past

  • RMTI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -614.29%.
  • The Revenue for RMTI has decreased by -31.76% in the past year. This is quite bad
  • The Revenue has been growing slightly by 2.17% on average over the past years.
EPS 1Y (TTM)-614.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-31.76%
Revenue growth 3Y-1.65%
Revenue growth 5Y2.17%
Sales Q2Q%-25.62%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.17% on average over the next years. This is a very strong growth
  • RMTI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.29% yearly.
EPS Next Y49%
EPS Next 2Y26.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.15%
Revenue Next 2Y7.29%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RMTI Yearly Revenue VS EstimatesRMTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
RMTI Yearly EPS VS EstimatesRMTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

Find the best growth stocksShow best growing peers

1

4. RMTI Valuation Analysis

4.1 Price/Earnings Ratio

  • RMTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year RMTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RMTI Price Earnings VS Forward Price EarningsRMTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RMTI Per share dataRMTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • RMTI's earnings are expected to grow with 26.17% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.17%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RMTI Dividend Analysis

5.1 Amount

  • No dividends for RMTI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RMTI Fundamentals: All Metrics, Ratios and Statistics

ROCKWELL MEDICAL INC

NASDAQ:RMTI (5/1/2026, 8:00:02 PM)

After market: 0.9 +0.01 (+1.33%)

0.8882

+0.01 (+1.29%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength16.77
Industry Growth32.3
Earnings (Last)03-26
Earnings (Next)05-07
Inst Owners8.92%
Inst Owner Change0.06%
Ins Owners4.14%
Ins Owner Change-0.02%
Market Cap35.00M
Revenue(TTM)69.26M
Net Income(TTM)-5.47M
Analysts82.5
Price Target3.06 (244.52%)
Short Float %2.89%
Short Ratio3.87
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.98%
Min EPS beat(2)-149.02%
Max EPS beat(2)-8.93%
EPS beat(4)2
Avg EPS beat(4)-33.61%
Min EPS beat(4)-149.02%
Max EPS beat(4)21.57%
EPS beat(8)4
Avg EPS beat(8)16.99%
EPS beat(12)7
Avg EPS beat(12)16.17%
EPS beat(16)11
Avg EPS beat(16)19.5%
Revenue beat(2)0
Avg Revenue beat(2)-3.53%
Min Revenue beat(2)-3.86%
Max Revenue beat(2)-3.21%
Revenue beat(4)1
Avg Revenue beat(4)-1.1%
Min Revenue beat(4)-3.86%
Max Revenue beat(4)6.2%
Revenue beat(8)5
Avg Revenue beat(8)1.94%
Revenue beat(12)7
Avg Revenue beat(12)1.01%
Revenue beat(16)9
Avg Revenue beat(16)0.99%
PT rev (1m)-20%
PT rev (3m)-20%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)28.57%
EPS NY rev (1m)-36.36%
EPS NY rev (3m)31.82%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)-1.84%
Revenue NY rev (3m)-1.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF N/A
P/OCF N/A
P/B 0.95
P/tB 1.33
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.08
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS1.76
BVpS0.94
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -9.57%
ROE -14.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.19%
FCFM N/A
ROA(3y)-9.02%
ROA(5y)-26.88%
ROE(3y)-18.94%
ROE(5y)-295.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.22%
GM growth 5Y33.51%
F-Score3
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.73%
Cap/Sales 0.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.98
Quick Ratio 3.63
Altman-Z -7.25
F-Score3
WACC8.37%
ROIC/WACCN/A
Cap/Depr(3y)315.6%
Cap/Depr(5y)214.54%
Cap/Sales(3y)5.63%
Cap/Sales(5y)3.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-614.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y49%
EPS Next 2Y26.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.76%
Revenue growth 3Y-1.65%
Revenue growth 5Y2.17%
Sales Q2Q%-25.62%
Revenue Next Year6.15%
Revenue Next 2Y7.29%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-723.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year156.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-137.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-115.68%
OCF growth 3YN/A
OCF growth 5YN/A

ROCKWELL MEDICAL INC / RMTI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ROCKWELL MEDICAL INC (RMTI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to RMTI.


What is the valuation status of ROCKWELL MEDICAL INC (RMTI) stock?

ChartMill assigns a valuation rating of 1 / 10 to ROCKWELL MEDICAL INC (RMTI). This can be considered as Overvalued.


Can you provide the profitability details for ROCKWELL MEDICAL INC?

ROCKWELL MEDICAL INC (RMTI) has a profitability rating of 2 / 10.


What is the earnings growth outlook for ROCKWELL MEDICAL INC?

The Earnings per Share (EPS) of ROCKWELL MEDICAL INC (RMTI) is expected to grow by 49% in the next year.